Association between a MYH9 polymorphism (rs3752462) and renal function in the Spanish RENASTUR cohort

Gene

Volumn 520, Issue 1, 2013, Pages 73-76

  Tavira, Beatriz ^a   Coto, Eliecer ^a,e   Gómez, Juan ^a   Tranche, Salvador ^b   Miguélez, Kevin ^b   Ortega, Francisco ^c,e   Díez, Beatriz ^d   Sánchez, Emilio ^c   Marín, Rafael ^c   Arenas, Jorge ^a   Alvarez, Victoria ^a  

^a HUCA   (Spain)

^b Centros de Salud Principado de Asturias   (Spain)

^c Hospital V Nalón ^*  (Spain)

^d Hospital V Nalón   (Spain)

^e RED INVESTIGACION RENAL REDINREN   (Spain)

Author keywords

Glomerular filtration; MYH9 polymorphisms; Renal function

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; GLOMERULUS FILTRATION RATE; HAPLOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MYH9 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; GLOMERULAR FILTRATION RATE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MOLECULAR MOTOR PROTEINS; MULTIVARIATE ANALYSIS; MYOSIN HEAVY CHAINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RENAL INSUFFICIENCY, CHRONIC; SPAIN;

EID: 84875813114     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.02.024     Document Type: Article

References (27)

1. Arrondel C., et al. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J. Am. Soc. Nephrol. 2002, 13:65-74.
2. Behar D.M., Rosset S., Tzur S., et al. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol Genet 2010, 19:1816-1827.
3. Böger C.A., et al. Association of eGFR-related loci identified by GWAS with incident CKD and ESRD. PLoS Genet. 2011, 7:e1002292.
4. Bostrom M.A., Freedman B.I. The spectrum of MYH9-associated nephropathy. Clin. J. Am. Soc. Nephrol. 2010, 5:1107-1113.
5. Cooke J.N., et al. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans. Nephrol. Dial. Transplant. 2012, 27:1505-1511.
6. Coresh J., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
7. Fox C.S., et al. Predictors of new-onset kidney disease in a community based population. JAMA 2004, 291:844-850.
8. Franceschini N., et al. The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study. Hum. Genet. 2010, 127(3):295-301. (Mar).
9. Freedman B.I., et al. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol. Dial. Transplant. 2009, 24:3366-3371.
10. Freedman B.I., et al. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am. J. Nephrol. 2009, 29:626-632.
11. García O., et al. Using mitochondrial DNA to test the hypothesis of a European post-glacial human recolonization from the Franco-Cantabrian refuge. Heredity 2011, 106:37-45.
12. Genovese G., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329:841-845.
13. Kao W.H., et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat. Genet. 2008, 40:1185-1192.
14. Kopp J.B., et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet. 2008, 40:1175-1184.
15. Köttgen A., et al. Multiple novel loci are associated with indices of renal function and chronic kidney disease. Nat. Genet. 2009, 41:712-717.
16. Köttgen A., et al. Multiple New loci associated with kidney function and chronic kidney disease. Nat. Genet. 2010, 42:376-384.
17. Levey A.S., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999, 130:461-470.
18. Lin C.P., et al. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun. 2012, 13:232-238.
19. Marini M., et al. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease. Int. J. Mol. Med. 2006, 17:729-736.
20. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002, 39(Suppl. 1):46-75.
21. Nelson G.W., et al. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum. Mol. Genet. 2010, 19:1805-1815.
22. O'Seaghdha C.M., et al. The MYH9/APOL1 region and chronic kidney disease in European-Americans. Hum. Mol. Genet. 2011, 20:2450-2456.
23. Oleksyk T.K., Nelson G.W., An P., Kopp J.B., Winkler C.A. Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. PLoS One 2010, 5:e11474.
24. Otero A., et al. Prevalencia de la insuficiencia renal crónica en España: resultados del estudio EPIRCE. Nefrologia 2010, 30:78-86.
25. Palacín M., et al. Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: evidence for an association to haplogroup H. Mitochondrion 2011, 11:176-181.
26. Pattaro C., et al. Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int. 2009, 76:297-306.
27. Seri M., et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner Syndrome Consortium. Nat. Genet. 2000, 26:103-105.